Ims Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IMS LTD, and what generic and branded alternatives to IMS LTD drugs are available?
IMS LTD has one approved drug.
Drugs and US Patents for Ims Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ims Ltd | REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 214252-001 | May 23, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.